Navigation Links
Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
Date:7/16/2012

GREENWOOD VILLAGE, Colo., July 16, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company developing repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction and conducting clinical trials on its four lead drugs (Ampion™, Optina™, Zertane™ & Zertane-ED™) announced today the advancement of NCE001, from its proprietary methylphenidate derivatives family of compounds, to preclinical development for the treatment of glioblastoma multiforme, renal cell carcinoma and inflammatory breast cancer following the granting of multiple composition of matter and use patents in the USA, Canada, Europe and China.

(Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)  

Dr. David Bar-Or, Ampio's Chief Science Officer (CSO) explained the focus on this particular drug, "NCE001 activates a specific intracellular phosphatase largely involved in inflammation, angiogenesis and cell proliferation pathways and has demonstrated remarkable in vitro effects on aggressive cancer cells of these three lineages.  We believe it may play an important role in treating these particularly aggressive cancers.  Ampio has entered into a development agreement with Syngene International (Bangalore, India) to manufacture and conduct all preclinical stages of development of NCE001 all the way to an IND submission to the FDA. These three cancers do not have adequate treatment options so NCE001 may qualify for an accelerated approval path by regulatory agencies including the FDA."

Michael Macaluso, Ampio's CEO noted, "Our recent successful financing and our confidence that we will successfully out-license our more advanced drugs means we need
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
2. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
3. Ampio Pharmaceuticals Announces Proposed Public Offering
4. Ampios CEO and CSO Send Message to Shareholders
5. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
6. Ampio Pharmaceuticals Schedules 2012 Update Webcast
7. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
8. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
9. Medical Imaging Information Systems Market to 2017 - Replacement of Legacy Systems and Advances in Software Present Growth Opportunities
10. Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic
11. Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... JORDAN, Utah , July 10, 2014  BC ... solutions, and MiE America , Inc., a leading ... have entered into a long-term agreement naming BC Technical ... the US. MiE and BC Technical ... strategic agreement to establish BC Technical as the service ...
(Date:7/10/2014)... -- CVS Caremark Corporation (NYSE: CVS ) today ... dividend of $0.275 (27.5 cents) per share on the corporation,s ... to holders of record on July 21, 2014. ... to helping people on their path to better health as ... States . Through the company,s more than 7,600 CVS/pharmacy ...
(Date:1/15/2014)... DUBLIN , Jan. 15, 2014  Research and Markets ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. (Logo: ... products which are used on patients in order to ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... SUNNYVALE, Calif. , June 3 Accuray ... the field of radiosurgery, today announced the installation of the ... of its acceptance as the world,s leading device for radiosurgery. ... in the United Kingdom , the first hospital operated ...
... , June 3 Perrigo Company (Nasdaq: PRGO ... the U.S. Food and Drug Administration for its abbreviated new drug ... generic to Monistat® -1 Combination Pack. Perrigo expects to begin shipping ... , ...
Cached Medicine Technology:Accuray Installs 200th CyberKnife Robotic Radiosurgery System 2Accuray Installs 200th CyberKnife Robotic Radiosurgery System 3Accuray Installs 200th CyberKnife Robotic Radiosurgery System 4Accuray Installs 200th CyberKnife Robotic Radiosurgery System 5Perrigo Announces FDA Final Approval for Miconazole 2Perrigo Announces FDA Final Approval for Miconazole 3
(Date:7/11/2014)... to understand the best available treatment for patients, from ... less costly for taxpayers than the existing clinical trial ... van Staa, carried out while he was a member ... is now based at The University of Manchester,s Health ... ( HTA ) today (Friday 11 July) looked at ...
(Date:7/11/2014)... Steven Reinberg HealthDay ... Stress, hostility and depression may increase the risk for stroke, ... seemed to raise the risk of a stroke or ... found that stress apparently raised stroke or TIA risk by ... A TIA is a mini-stroke caused by a temporary blockage ...
(Date:7/11/2014)... Aarhus University has revealed that people who have grown ... as likely as their urban counterparts to develop the ... disease. The study findings have recently been published in ... is extremely exciting that we can now see that ... diseases appear to depend on the environment we are ...
(Date:7/11/2014)... 2014 As reported by Forbes in ... Are Genetics To Blame (6/30), Indino Downey has reportedly ... paraphernalia to smoke it with. His father, well-known actor ... son inherited from him may have something to do ... news during the 1980s and 1990s for substance abuse ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Having experienced mental ... a member of mental hospital staff, Roger Grainger gives readers ... professionals in his new book, “You Never Get Out.” , ... in the United Kingdom will experience some kind of mental ... “Society still needs to take a look at the way ...
Breaking Medicine News(10 mins):Health News:Better use of electronic health records makes clinical trials less expensive 2Health News:Stress, Depression May Boost Stroke Risk, Study Finds 2Health News:Stress, Depression May Boost Stroke Risk, Study Finds 3Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2Health News:Roberty Downey's Son Arrested For Cocaine 2Health News:Psychiatric Hospital Patient and Registered Psychologist Explores Mental Health and Therapy in New Book "You Never Get Out" 2
... (TORONTO Nov. 28, 2011) A second, larger clinical ... Hospital (PMH) has again proven that comparing a new biopsy ... cancer can dictate a change in treatment. The ... Journal of Clinical Oncology . Principal investigator Dr. ...
... areas in the brain,s left hemisphere enable us to understand ... those areas divvy up the highly complex processes necessary to ... within the last 10 years have revealed that highly complex ... particular regions of the cerebral cortex, but also on the ...
... MONDAY, Nov. 28 (HealthDay News) -- Most U.S. heart ... hospital for a procedure to open narrowed or blocked ... 30 minutes or less, new research shows. The ... procedures such as balloon angioplasty or stent placement (called ...
... Academic institutions in Sweden are among the quickest to adopt ... Experiments ( JoVE ), with over 35 percent of ... for this phenomenon is that Swedes are among the fastest ... think we are a very curious people and interested in ...
... between breakfast and lunch lose less weight compared to those ... led by researchers at Fred Hutchinson Cancer Research Center., The ... Ph.D., a member of the Hutchinson Center,s Public Health Sciences ... in the December issue of the Journal of the ...
... a second primary cancer of the same type, according to ... Association Journal ) (pre-embargo link only) http://www.cmaj.ca/site/embargo/cmaj110167.pdf , whereas ... was only slightly elevated. Danish researchers looked at data ... people) from 1980 to 2007 to determine whether the risk ...
Cached Medicine News:Health News:New study shows biopsy of recurrent breast cancer can alter treatment 2Health News:How the brain strings words into sentences 2Health News:How the brain strings words into sentences 3Health News:How the brain strings words into sentences 4Health News:Lengthy Hospital Transfers May Hamper Heart Attack Care 2Health News:Swedish people are quick to adopt JoVE, a video journal for biomedical sciences 2Health News:Mid-morning snacking may sabotage weight-loss efforts 2Health News:Mid-morning snacking may sabotage weight-loss efforts 3Health News:Risk of second cancer in cancer survivors mainly confined to the same cancer type as the first 2Health News:Risk of second cancer in cancer survivors mainly confined to the same cancer type as the first 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... used in the ARED study, as well ... which suggested no AMD disease progression in ... period. Macula Complete also contains efficacious amounts ... support the mitochondria, as well as to ...
... MacularProtect delivers levels of ... vision and macular health in ... by The National Eye Institute. ... of lutein, an antioxidant found ...
... is a scientifically advanced nutritional formulation ... and full body health. MacularProtect Complete ... trial and other advanced research. It ... provides a broad foundation of antioxidants, ...
Medicine Products: